Review




Structured Review

Moderna mrna 1273 vaccines are lipid nanoparticle
Mrna 1273 Vaccines Are Lipid Nanoparticle, supplied by Moderna, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mrna-1273+vaccine/1273+mrna+%D0%B8%D0%BB%D0%B8/pm42283396-39-5-4
Average 86 stars, based on 1 article reviews
mrna 1273 vaccines are lipid nanoparticle - by Bioz Stars, 2026-10
86/100 stars

Images

Related Articles

Lyophilization:

Article Title: The effects of SARS-CoV-2 vaccines on antinuclear autoantibody formation in individuals without prior COVID-19 infection.
Article Snippet: Background: Viral particles in SARS-CoV-2 vaccines have molecular motifs resembling self-antigens, potentially triggering autoantibody production.. This study aimed to investigate the effects of mRNA vaccines (BioNTech), which contain a single viral particle, and inactivated whole viral particles (Sinovac) on antinuclear autoantibody (ANA) formation in individuals without prior COVID-19 infection.. Material and Methods: The study was retrospective and included individuals who had not contracted SARSCoV-2 (tested negative for antigen or antibody).

Article Title: The safety of COVID-19 vaccines in a large French series of patients with neuromuscular conditions and the impacts of vaccination on their daily lives.
Article Snippet: This prospective observational study assessed how well patients with neuromuscular disorders (NMDs) tolerated coronavirus disease 2019 (COVID-19) vaccination, and the safety thereof.. Patients treated in 55 expert centres of the French NMD (FILNEMUS) network were asked to complete online questionnaires that explored COVID-19 vaccine injection status, adverse effects (AEs), and the impacts thereof on the activities of daily living (ADLs).. All patients were followed-up for 12 months.

Article Title: EBV Vaccines in the Prevention and Treatment of Nasopharyngeal Carcinoma.
Article Snippet: For example, mRNA molecules are susceptible to degradation by RNases in vitro, have a short half-life, and require specialized delivery systems such as lipid nanoparticles (LNPs) to protect them from degradation. mRNA vaccines typically need to be stored and transported at low temperatures; for example, Moderna’s mRNA-1273 vaccine requires storage at approximately −20 ◦C (NCT04470427).

Article Title: Biomaterials nanoplatform-based tumor vaccines for immunotherapy
Article Snippet: The LNP stability in the mRNA-1273 vaccine (Moderna) was achieved via lyophilization optimization and ionizable lipid engineering, and the stability was instrumental for scalable manufacturing and eliciting robust immunogenicity during Phase III trials.

Article Title: A cohort of mRNAs undergo high-stoichiometry NSUN6-mediated site-specific m 5 C modification.
Article Snippet: The mRNA-1273 vaccine, developed by Moderna, has demonstrated clinical effectiveness in preventing SARS-CoV-2 infection70.

Article Title: Gender equity and COVID-19 vaccine policies for pregnant people: a global analysis.
Article Snippet: Interim recommendations for use of the Moderna mRNA-1273 vaccine against COVID-19 [Internet].

Article Title: A Multiscale Quantitative Systems Pharmacology Model for the Development and Optimization of mRNA Vaccines
Article Snippet: Furthermore, the model's adaptability has been demonstrated through its calibration for other mRNA vaccines, such as the Moderna mRNA‐1273 vaccine, emphasizing its versatility and broad applicability in mRNA vaccine research and development.

Article Title: SARS-CoV-2-specific humoral and cellular immunity assessment in Peruvian vaccinated population: a cross-sectional study
Article Snippet: By late 2021, booster doses were introduced, employing both homologous and heterologous schemes, including the mRNA-1273 (Moderna) vaccine, with a minimum interval of 3 months after the second dose ( ).

Immunopeptidomics:

Article Title: The effects of SARS-CoV-2 vaccines on antinuclear autoantibody formation in individuals without prior COVID-19 infection.
Article Snippet: Background: Viral particles in SARS-CoV-2 vaccines have molecular motifs resembling self-antigens, potentially triggering autoantibody production.. This study aimed to investigate the effects of mRNA vaccines (BioNTech), which contain a single viral particle, and inactivated whole viral particles (Sinovac) on antinuclear autoantibody (ANA) formation in individuals without prior COVID-19 infection.. Material and Methods: The study was retrospective and included individuals who had not contracted SARSCoV-2 (tested negative for antigen or antibody).

Article Title: The safety of COVID-19 vaccines in a large French series of patients with neuromuscular conditions and the impacts of vaccination on their daily lives.
Article Snippet: This prospective observational study assessed how well patients with neuromuscular disorders (NMDs) tolerated coronavirus disease 2019 (COVID-19) vaccination, and the safety thereof.. Patients treated in 55 expert centres of the French NMD (FILNEMUS) network were asked to complete online questionnaires that explored COVID-19 vaccine injection status, adverse effects (AEs), and the impacts thereof on the activities of daily living (ADLs).. All patients were followed-up for 12 months.

Article Title: EBV Vaccines in the Prevention and Treatment of Nasopharyngeal Carcinoma.
Article Snippet: For example, mRNA molecules are susceptible to degradation by RNases in vitro, have a short half-life, and require specialized delivery systems such as lipid nanoparticles (LNPs) to protect them from degradation. mRNA vaccines typically need to be stored and transported at low temperatures; for example, Moderna’s mRNA-1273 vaccine requires storage at approximately −20 ◦C (NCT04470427).

Article Title: Biomaterials nanoplatform-based tumor vaccines for immunotherapy
Article Snippet: The LNP stability in the mRNA-1273 vaccine (Moderna) was achieved via lyophilization optimization and ionizable lipid engineering, and the stability was instrumental for scalable manufacturing and eliciting robust immunogenicity during Phase III trials.

Article Title: A cohort of mRNAs undergo high-stoichiometry NSUN6-mediated site-specific m 5 C modification.
Article Snippet: The mRNA-1273 vaccine, developed by Moderna, has demonstrated clinical effectiveness in preventing SARS-CoV-2 infection70.

Article Title: Gender equity and COVID-19 vaccine policies for pregnant people: a global analysis.
Article Snippet: Interim recommendations for use of the Moderna mRNA-1273 vaccine against COVID-19 [Internet].

Article Title: A Multiscale Quantitative Systems Pharmacology Model for the Development and Optimization of mRNA Vaccines
Article Snippet: Furthermore, the model's adaptability has been demonstrated through its calibration for other mRNA vaccines, such as the Moderna mRNA‐1273 vaccine, emphasizing its versatility and broad applicability in mRNA vaccine research and development.

Article Title: SARS-CoV-2-specific humoral and cellular immunity assessment in Peruvian vaccinated population: a cross-sectional study
Article Snippet: By late 2021, booster doses were introduced, employing both homologous and heterologous schemes, including the mRNA-1273 (Moderna) vaccine, with a minimum interval of 3 months after the second dose ( ).

Injection:

Article Title: The effects of SARS-CoV-2 vaccines on antinuclear autoantibody formation in individuals without prior COVID-19 infection.
Article Snippet: Background: Viral particles in SARS-CoV-2 vaccines have molecular motifs resembling self-antigens, potentially triggering autoantibody production.. This study aimed to investigate the effects of mRNA vaccines (BioNTech), which contain a single viral particle, and inactivated whole viral particles (Sinovac) on antinuclear autoantibody (ANA) formation in individuals without prior COVID-19 infection.. Material and Methods: The study was retrospective and included individuals who had not contracted SARSCoV-2 (tested negative for antigen or antibody).

Article Title: The safety of COVID-19 vaccines in a large French series of patients with neuromuscular conditions and the impacts of vaccination on their daily lives.
Article Snippet: This prospective observational study assessed how well patients with neuromuscular disorders (NMDs) tolerated coronavirus disease 2019 (COVID-19) vaccination, and the safety thereof.. Patients treated in 55 expert centres of the French NMD (FILNEMUS) network were asked to complete online questionnaires that explored COVID-19 vaccine injection status, adverse effects (AEs), and the impacts thereof on the activities of daily living (ADLs).. All patients were followed-up for 12 months.

Article Title: EBV Vaccines in the Prevention and Treatment of Nasopharyngeal Carcinoma.
Article Snippet: For example, mRNA molecules are susceptible to degradation by RNases in vitro, have a short half-life, and require specialized delivery systems such as lipid nanoparticles (LNPs) to protect them from degradation. mRNA vaccines typically need to be stored and transported at low temperatures; for example, Moderna’s mRNA-1273 vaccine requires storage at approximately −20 ◦C (NCT04470427).

Article Title: Biomaterials nanoplatform-based tumor vaccines for immunotherapy
Article Snippet: The LNP stability in the mRNA-1273 vaccine (Moderna) was achieved via lyophilization optimization and ionizable lipid engineering, and the stability was instrumental for scalable manufacturing and eliciting robust immunogenicity during Phase III trials.

Article Title: A cohort of mRNAs undergo high-stoichiometry NSUN6-mediated site-specific m 5 C modification.
Article Snippet: The mRNA-1273 vaccine, developed by Moderna, has demonstrated clinical effectiveness in preventing SARS-CoV-2 infection70.

Article Title: Gender equity and COVID-19 vaccine policies for pregnant people: a global analysis.
Article Snippet: Interim recommendations for use of the Moderna mRNA-1273 vaccine against COVID-19 [Internet].

Article Title: A Multiscale Quantitative Systems Pharmacology Model for the Development and Optimization of mRNA Vaccines
Article Snippet: Furthermore, the model's adaptability has been demonstrated through its calibration for other mRNA vaccines, such as the Moderna mRNA‐1273 vaccine, emphasizing its versatility and broad applicability in mRNA vaccine research and development.

Article Title: SARS-CoV-2-specific humoral and cellular immunity assessment in Peruvian vaccinated population: a cross-sectional study
Article Snippet: By late 2021, booster doses were introduced, employing both homologous and heterologous schemes, including the mRNA-1273 (Moderna) vaccine, with a minimum interval of 3 months after the second dose ( ).

In Vitro:

Article Title: The effects of SARS-CoV-2 vaccines on antinuclear autoantibody formation in individuals without prior COVID-19 infection.
Article Snippet: Background: Viral particles in SARS-CoV-2 vaccines have molecular motifs resembling self-antigens, potentially triggering autoantibody production.. This study aimed to investigate the effects of mRNA vaccines (BioNTech), which contain a single viral particle, and inactivated whole viral particles (Sinovac) on antinuclear autoantibody (ANA) formation in individuals without prior COVID-19 infection.. Material and Methods: The study was retrospective and included individuals who had not contracted SARSCoV-2 (tested negative for antigen or antibody).

Article Title: The safety of COVID-19 vaccines in a large French series of patients with neuromuscular conditions and the impacts of vaccination on their daily lives.
Article Snippet: This prospective observational study assessed how well patients with neuromuscular disorders (NMDs) tolerated coronavirus disease 2019 (COVID-19) vaccination, and the safety thereof.. Patients treated in 55 expert centres of the French NMD (FILNEMUS) network were asked to complete online questionnaires that explored COVID-19 vaccine injection status, adverse effects (AEs), and the impacts thereof on the activities of daily living (ADLs).. All patients were followed-up for 12 months.

Article Title: EBV Vaccines in the Prevention and Treatment of Nasopharyngeal Carcinoma.
Article Snippet: For example, mRNA molecules are susceptible to degradation by RNases in vitro, have a short half-life, and require specialized delivery systems such as lipid nanoparticles (LNPs) to protect them from degradation. mRNA vaccines typically need to be stored and transported at low temperatures; for example, Moderna’s mRNA-1273 vaccine requires storage at approximately −20 ◦C (NCT04470427).

Article Title: Biomaterials nanoplatform-based tumor vaccines for immunotherapy
Article Snippet: The LNP stability in the mRNA-1273 vaccine (Moderna) was achieved via lyophilization optimization and ionizable lipid engineering, and the stability was instrumental for scalable manufacturing and eliciting robust immunogenicity during Phase III trials.

Article Title: A cohort of mRNAs undergo high-stoichiometry NSUN6-mediated site-specific m 5 C modification.
Article Snippet: The mRNA-1273 vaccine, developed by Moderna, has demonstrated clinical effectiveness in preventing SARS-CoV-2 infection70.

Article Title: Gender equity and COVID-19 vaccine policies for pregnant people: a global analysis.
Article Snippet: Interim recommendations for use of the Moderna mRNA-1273 vaccine against COVID-19 [Internet].

Article Title: A Multiscale Quantitative Systems Pharmacology Model for the Development and Optimization of mRNA Vaccines
Article Snippet: Furthermore, the model's adaptability has been demonstrated through its calibration for other mRNA vaccines, such as the Moderna mRNA‐1273 vaccine, emphasizing its versatility and broad applicability in mRNA vaccine research and development.

Article Title: SARS-CoV-2-specific humoral and cellular immunity assessment in Peruvian vaccinated population: a cross-sectional study
Article Snippet: By late 2021, booster doses were introduced, employing both homologous and heterologous schemes, including the mRNA-1273 (Moderna) vaccine, with a minimum interval of 3 months after the second dose ( ).

Vaccines:

Article Title: The effects of SARS-CoV-2 vaccines on antinuclear autoantibody formation in individuals without prior COVID-19 infection.
Article Snippet: Background: Viral particles in SARS-CoV-2 vaccines have molecular motifs resembling self-antigens, potentially triggering autoantibody production.. This study aimed to investigate the effects of mRNA vaccines (BioNTech), which contain a single viral particle, and inactivated whole viral particles (Sinovac) on antinuclear autoantibody (ANA) formation in individuals without prior COVID-19 infection.. Material and Methods: The study was retrospective and included individuals who had not contracted SARSCoV-2 (tested negative for antigen or antibody).

Article Title: The safety of COVID-19 vaccines in a large French series of patients with neuromuscular conditions and the impacts of vaccination on their daily lives.
Article Snippet: This prospective observational study assessed how well patients with neuromuscular disorders (NMDs) tolerated coronavirus disease 2019 (COVID-19) vaccination, and the safety thereof.. Patients treated in 55 expert centres of the French NMD (FILNEMUS) network were asked to complete online questionnaires that explored COVID-19 vaccine injection status, adverse effects (AEs), and the impacts thereof on the activities of daily living (ADLs).. All patients were followed-up for 12 months.

Article Title: EBV Vaccines in the Prevention and Treatment of Nasopharyngeal Carcinoma.
Article Snippet: For example, mRNA molecules are susceptible to degradation by RNases in vitro, have a short half-life, and require specialized delivery systems such as lipid nanoparticles (LNPs) to protect them from degradation. mRNA vaccines typically need to be stored and transported at low temperatures; for example, Moderna’s mRNA-1273 vaccine requires storage at approximately −20 ◦C (NCT04470427).

Article Title: Biomaterials nanoplatform-based tumor vaccines for immunotherapy
Article Snippet: The LNP stability in the mRNA-1273 vaccine (Moderna) was achieved via lyophilization optimization and ionizable lipid engineering, and the stability was instrumental for scalable manufacturing and eliciting robust immunogenicity during Phase III trials.

Article Title: A cohort of mRNAs undergo high-stoichiometry NSUN6-mediated site-specific m 5 C modification.
Article Snippet: The mRNA-1273 vaccine, developed by Moderna, has demonstrated clinical effectiveness in preventing SARS-CoV-2 infection70.

Article Title: Gender equity and COVID-19 vaccine policies for pregnant people: a global analysis.
Article Snippet: Interim recommendations for use of the Moderna mRNA-1273 vaccine against COVID-19 [Internet].

Article Title: A Multiscale Quantitative Systems Pharmacology Model for the Development and Optimization of mRNA Vaccines
Article Snippet: Furthermore, the model's adaptability has been demonstrated through its calibration for other mRNA vaccines, such as the Moderna mRNA‐1273 vaccine, emphasizing its versatility and broad applicability in mRNA vaccine research and development.

Article Title: SARS-CoV-2-specific humoral and cellular immunity assessment in Peruvian vaccinated population: a cross-sectional study
Article Snippet: By late 2021, booster doses were introduced, employing both homologous and heterologous schemes, including the mRNA-1273 (Moderna) vaccine, with a minimum interval of 3 months after the second dose ( ).



Similar Products

86
Moderna mrna 1273 vaccines are lipid nanoparticle
Mrna 1273 Vaccines Are Lipid Nanoparticle, supplied by Moderna, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mrna-1273+vaccine/1273+mrna+%D0%B8%D0%BB%D0%B8/pm42283396-39-5-4
Average 86 stars, based on 1 article reviews
mrna 1273 vaccines are lipid nanoparticle - by Bioz Stars, 2026-10
86/100 stars
  Buy from Supplier

86
Moderna mrna 1273 vaccine
Mrna 1273 Vaccine, supplied by Moderna, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mrna-1273+vaccine/1273+mrna+%D0%B8%D0%BB%D0%B8/pm42260046-136-115-105
Average 86 stars, based on 1 article reviews
mrna 1273 vaccine - by Bioz Stars, 2026-10
86/100 stars
  Buy from Supplier

86
Moderna mrna 1273 moderna vaccine
Mrna 1273 Moderna Vaccine, supplied by Moderna, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mrna-1273+vaccine/1273+mrna+%D0%B8%D0%BB%D0%B8/pm42260046-249-8-9
Average 86 stars, based on 1 article reviews
mrna 1273 moderna vaccine - by Bioz Stars, 2026-10
86/100 stars
  Buy from Supplier

86
Moderna moderna s mrna 1273 vaccine
Moderna S Mrna 1273 Vaccine, supplied by Moderna, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mrna-1273+vaccine/1273+mrna+%D0%B8%D0%BB%D0%B8/pm42252246-1-18-18
Average 86 stars, based on 1 article reviews
moderna s mrna 1273 vaccine - by Bioz Stars, 2026-10
86/100 stars
  Buy from Supplier

86
Moderna mrna 1273 vaccination
Mrna 1273 Vaccination, supplied by Moderna, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mrna-1273+vaccine/1273+mrna+%D0%B8%D0%BB%D0%B8/pmc13255034-64-80-44
Average 86 stars, based on 1 article reviews
mrna 1273 vaccination - by Bioz Stars, 2026-10
86/100 stars
  Buy from Supplier

86
Moderna moderna mrna 1273 vaccine
Moderna Mrna 1273 Vaccine, supplied by Moderna, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mrna-1273+vaccine/1273+mrna+%D0%B8%D0%BB%D0%B8/pm42167688-417-5-5
Average 86 stars, based on 1 article reviews
moderna mrna 1273 vaccine - by Bioz Stars, 2026-10
86/100 stars
  Buy from Supplier

86
Keio University Press Inc mrna 1273 sars cov 2 vaccine
Mrna 1273 Sars Cov 2 Vaccine, supplied by Keio University Press Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mrna-1273+vaccine/1273+2+cov+mrna+sars+vaccine/pm42154963-292-23-30
Average 86 stars, based on 1 article reviews
mrna 1273 sars cov 2 vaccine - by Bioz Stars, 2026-10
86/100 stars
  Buy from Supplier

86
Moderna covid 19 mrna vaccines mrna 1273
Covid 19 Mrna Vaccines Mrna 1273, supplied by Moderna, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mrna-1273+vaccine/1273+mrna+%D0%B8%D0%BB%D0%B8/pmc13158380-465-2-6
Average 86 stars, based on 1 article reviews
covid 19 mrna vaccines mrna 1273 - by Bioz Stars, 2026-10
86/100 stars
  Buy from Supplier

86
Moderna mrna covid 19 vaccine include mrna 1273
Mrna Covid 19 Vaccine Include Mrna 1273, supplied by Moderna, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mrna-1273+vaccine/1273+mrna+%D0%B8%D0%BB%D0%B8/pm42083745-35-5-10
Average 86 stars, based on 1 article reviews
mrna covid 19 vaccine include mrna 1273 - by Bioz Stars, 2026-10
86/100 stars
  Buy from Supplier

86
Moderna moderna mrna 1273 covid 19 vaccines
Moderna Mrna 1273 Covid 19 Vaccines, supplied by Moderna, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mrna-1273+vaccine/1273+mrna+%D0%B8%D0%BB%D0%B8/pm42092664-269-13-13
Average 86 stars, based on 1 article reviews
moderna mrna 1273 covid 19 vaccines - by Bioz Stars, 2026-10
86/100 stars
  Buy from Supplier

Image Search Results